News

Under the terms of the agreement, the first phase of the partnership will commence immediately, and will include the commercialization and exporting of existing Organogenesis technology, including its

The program includes a set of four trials evaluating a variety of obesity-related outcome measures, which together are expected to support the new drug application for approval of

The manager of the drugs control department said that importation of Oral-lyn can be done via the issuance of a purchase order from the Imperial College London Diabetes

A range of active compounds are protected, each related to the active ingredient in PV-10. Provectus is currently conducting Phase II clinical trials of its proprietary drugs PV-10

Daniel Carr, CEO and CMO of Javelin, said: “Today is a watershed in Javelin’s evolution from a development company to a revenue-generating organization. Pricing publication marks the UK

The completion of the sale of the assets will launch effectively Ore Pharmaceuticals as a new company focused on drug repositioning and development. Ownership of the name Gene

The primary objectives of this Phase Ia study were to characterize the safety, tolerability and pharmacokinetics of a single dose of IL-29 administered subcutaneously. A total of 20

Under the terms of the agreement, Cyclacel will determine the exact timing and amount of any committed equity financing facility (CEFF) financings, subject to certain conditions. Kingsbridge is

According to the terms of the agreement, Anesiva is entitled to an undisclosed up-front payment and a fixed transfer price. Medical Futures will be responsible for all the